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RESEARCH
Venezuelan equine encephalitis virus (VEEV) is an 
emerging pathogen of equids and humans, but infection of 
its rodent reservoir hosts has received little study. To de-
termine whether responses to infection vary among geo-
graphic populations, we inoculated 3 populations of cotton 
rats with 2 enzootic VEEV strains (Co97-0054 [enzootic ID 
subtype] and 68U201 [enzootic IE subtype]). The 3 popula-
tions were offspring from wild-caught cotton rats collected 
in a VEE-enzootic area of south Florida, USA; wild-caught 
cotton rats from a non–VEE-enzootic area of Texas, USA; 
and commercially available (Harlan) colony-reared cotton 
rats from a non–VEE-enzootic region. Although each popu-
lation had similar early viremia titers, no detectable disease 
developed in the VEE-sympatric Florida animals, but severe 
disease and death affected the Texas and Harlan animals. 
Our ﬁ  ndings suggest that the geographic origins of cotton 
rats are important determinants of the outcome of VEE in-
fection and reservoir potential of these rodents.
V
ertebrate reservoir hosts play an important role in 
maintenance and dissemination of zoonotic patho-
gens. For arthropodborne viruses (arboviruses), infected 
hosts generally show little or no disease, which presumably 
reﬂ  ects long-term selection for host resistance and possibly 
virus attenuation (1,2). Understanding how pathogens af-
fect their reservoir hosts as well as how the reservoir af-
fects ﬁ  tness and replication of the pathogen could enable 
better prediction of emergence, reemergence, or extinction 
of zoonotic pathogens in response to environmental chang-
es. For example, changes in a reservoir host’s habitats and 
ecology, due to anthropogenic or natural causes, may affect 
pathogen transmission to humans and domestic animals. A 
better understanding of reservoir biology and of pathogen-
reservoir interactions, particularly their mechanisms of 
disease resistance, could also facilitate the development of 
treatment and control strategies for humans and domestic 
animals (3,4).
Venezuelan equine encephalitis virus (VEEV), a mem-
ber of the family Togaviridae, genus Alphavirus (5), was 
ﬁ  rst isolated and characterized in 1938 (6,7) and affects hu-
mans and equids in the Americas (8,9). VEEV strains are 
classiﬁ  ed into 2 epidemiologic groups: enzootic and epizo-
otic. Enzootic strains (subtype I, varieties D and E, as well 
as related species in the VEE complex comprising subtypes 
II–VI) have been regularly isolated in lowland tropical for-
ests and swamps in Florida, Mexico, and Central and South 
America. These enzootic viruses generally circulate be-
tween Culex (Melanoconion) spp. mosquito vectors and ro-
dent reservoirs and are usually avirulent for and incapable 
of ampliﬁ  cation in equids (8). In contrast, epizootic (and 
epidemic) VEEV strains (subtype I, variety AB and variety 
C), have been responsible for all major equine outbreaks 
that have involved other mosquito vectors, primarily Ae-
des and Psorophora spp. Epizootics and epidemics have 
occurred from southern North America to northern South 
America, and the VEEV strains involved have caused 
debilitating neurologic disease with high fatality rates in 
equids (9–11). In humans, who are tangential hosts dur-
ing endemic and epizootic cycles, severe febrile illness can 
become life threatening. Although <1% of infected humans 
die, permanent neurologic sequelae can occur in survivors, 
particularly young children (8,12,13).
Serosurveys have found VEEV antibodies in many 
species of small mammals (14–18). However, spiny rats 
(Proechimys spp., family Echimyidae) and cotton rats (Sig-
modon spp., family Cricetidae) have been most often impli-
cated as principal reservoir hosts for enzootic strains, based 
on seroprevalence and experimental infections demonstrat-
ing viremia adequate in titer and duration to infect enzootic 
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mosquito vectors (19–22). Their geographic distributions 
are different, but overlapping: Proechimys spp. are found 
mainly in Panama, northern Peru, Bolivia, Paraguay, and 
Brazil;  Sigmodon spp. are found mainly from southern 
North America to northern parts of Venezuela, Colombia, 
and Peru (23).
Studies supporting the role of cotton rats as reservoir 
hosts for enzootic VEEV have investigated viremia and an-
tibody responses as well as horizontal transmission in labo-
ratory settings (19–21,24,25). Howard et al. reported illness 
and death in cotton rats after infection with a Texas epizo-
otic subtype IB strain (21). The cause of death was linked 
more to experimental manipulation than to virus infection. 
Another study that examined clinical and histopathologic 
manifestations after infection of rats with Everglades virus 
(EVEV; subtype II in the VEE complex) reported that al-
though viremia developed and the virus replicated in a wide 
variety of organs, only 2% died (25).
The southern United States has 12 native subspecies 
of cotton rats (26), which differ by as much as 5% in their 
cytochrome b DNA sequence (27). To determine whether 
responses to infection vary among these geographic popu-
lations, we studied infection with 2 different subtypes of 
enzootic VEEV in 3 populations of cotton rats.
Materials and Methods
Animals
Three subspecies of Sigmodon hispidus (cotton rat) 
were used in this study: the Harlan colony, the Texas 
population, and the Florida population. The Harlan colony 
consisted of 6- to 8-week-old female rats purchased from 
Harlan (Indianapolis, IN, USA) from an established colo-
ny. Because the exact geographic origin was unknown, cy-
tochrome B mitochondrial gene sequences were ampliﬁ  ed 
by PCR and compared phylogenetically with those from 
cotton rats from various locations in North America (27). 
The sequences from the Harlan colony grouped with those 
of animals collected in east Texas, Louisiana, and Tennes-
see but were outside of the clade from southern Florida 
(data not shown), which indicated that these rats originated 
from a nonenzootic region. (Florida is the only VEE com-
plex alphavirus–enzootic region in the United States, aside 
from the Rocky Mountains, which are outside of Sigmodon 
distribution [8,23]). The Texas population consisted of 4- 
to 12-month-old wild-caught male and female S. hispidus 
berlandieri trapped in Galveston Island State Park, Texas 
(29.27°N, 94.83°W) (25). The Florida population consisted 
of 3- to 21-week-old male and female cotton rats (S. hispi-
dus spadicipygus) trapped in southern Florida (25) and used 
to rear F1 rats for experimental studies. Before inoculation, 
all rats were tested for antibodies against VEEV, EVEV, 
and Eastern equine encephalitis virus (EEEV) and accli-
mated for 3 days in a Biosafety Level 3 animal facility. All 
experiments included >2 animals as negative controls. All 
studies were approved by the University of Texas Medical 
Branch Animal Care and Use Committee.
Viruses and Infections
VEEV strain Co97-0054 (enzootic ID subtype), iso-
lated in Colombia in 1997 from a sentinel hamster, and 
strain 68U201 (enzootic IE), isolated in Guatemala from 
a sentinel hamster and derived from a cDNA clone (28), 
were used for experimental infections. These strains were 
selected because they had low passage histories and rep-
resent the 2 major enzootic VEEV subtypes; strain Co97-
0054 has also been used for experimental infection of spiny 
rats (22). Cotton rats were inoculated subcutaneously in 
the left footpad or left thigh with 3–4 log10 PFU of virus, 
a dose consistent with the maximum amount of VEEV in 
mosquito saliva (29). To determine whether an increase in 
virus inoculum could change the outcome of the disease, 
4 Florida rats were also inoculated with 5–6 log10 PFU of 
VEEV strain 68U201. All animals were observed for signs 
of illness once a day for 15 days.
To determine the neurovirulence of VEEV in the Flor-
ida population, 3 rats (2 months of age) were inoculated in-
tracranially with 3 log10 PFU/mL of strain 68U201. Blood 
samples were collected 24 h after inoculation, and the rats 
were observed for signs of disease.
Viremia Assays
Blood samples were collected from the retroorbital 
sinus for <10 days after inoculation. Serum samples were 
diluted 1:10 in Eagle minimal essential medium supple-
mented with 20% fetal bovine serum, gentamicin, and L-
glutamine and stored at –80°C. Viremia titers were deter-
mined by plaque assay with Vero cells (30).
Antibody Assays
Plaque reduction (80%) neutralization (PRNT) and 
hemagglutination inhibition (HI) tests were performed 
(30). To detect speciﬁ  c VEEV immunoglobulin M (IgM) 
antibodies, an IgM-capture ELISA was performed (31). 
Brieﬂ  y, microplates were coated with anti-rat IgM, diluted 
1:500 in carbonate-bicarbonate buffer pH 9.6 (Kirkegaard 
and Perry Laboratories, Gaithersburg, MD, USA), and in-
cubated at 4ºC for at least 16 h. Subsequently, the follow-
ing were sequentially added: test serum, mouse immune 
ascitic ﬂ  uid prepared against VEEV antigens, anti-mouse 
conjugate (Kirkegaard and Perry), and ABTS (2,2′-azino-
bis[3-ethylbenzthiazoline-6-sulphonic acid])–peroxidase 
substrate (Kirkegaard and Perry). Test serum samples were 
diluted at 1:40 in 0.5% bovine serum albumin in phosphate-
buffered saline at pH 7.4, and the plates were read by using 
a spectrophotometer with a 405-nm wavelength ﬁ  lter. The RESEARCH
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cut-off value was calculated as the mean optical density 
(OD)405 nm of negative control samples plus 3 standard de-
viations, or 0.200. Linear regression, the Student t test, and 
analysis of variance were used to analyze data.
Results
Clinical Responses and Survival
Inoculation of the Florida rats with 3 log10 PFU of 
VEEV strain 68U201 (IE) or Co97-0054 (ID) resulted in 
no detectable signs of illness and survival rates of 100% 
and 87.5%, respectively (Figure 1). One Florida rat inocu-
lated with strain Co97-0054 died on day 10 postinocula-
tion without exhibiting any signs of illness. These ﬁ  ndings 
contrasted with the results of VEEV infections of the Texas 
and Harlan populations. Although the Harlan rats were in-
oculated with only the subtype ID strain, signs of severe 
illness developed in all of the Harlan and Texas rats begin-
ning on day 5. Signs included rufﬂ  ed coats, lack of groom-
ing, lethargy, and for many, signs of encephalitis (incoordi-
nation and instability when walking and erratic movements 
of the head and limbs), dehydration (measured by lack of 
skin turgor), and anorexia. Most animals that died before 
day 5 postinoculation showed no prior signs of illness. The 
average survival time for the Texas population was 6.8 
days after inoculation with the subtype ID strain and 8.2 
days with the IE strain; for the Harlan colony, it was 5 days 
after inoculation with the subtype ID VEEV. None of the 
animals that survived past day 15 died. The 2 sham-inocu-
lated and the 2 noninoculated rats survived without signs 
of disease.
Neurovirulence in Florida Cotton Rats
To determine whether the absence of disease in the 
Florida population was due to the inability of the virus to 
penetrate the central nervous system, 3 rats were inoculated 
intracranially with 3 log10 PFU/mL of subtype IE VEEV. 
Viremia titers at 24 h postinoculation were 6.3, 6.2, and 6.8 
log10 PFU/mL (mean 6.5). By day 3 postinoculation, all of 
these rats started showing signs of illness, including rufﬂ  ing 
of the fur and lack of movement. By day 9 postinoculation, 
1 rat was dead and the other 2 exhibited instability and dif-
ﬁ  culty in walking, uncoordinated and erratic movements 
of the head and limbs, dehydration, and anorexia; these 
animals were euthanized because of the severity of disease. 
Histopathologic examination of the brains showed clear 
signs of encephalitis, focal meningoencephalitis (Figure 2, 
panels A, B) and associated perivascular mononuclear cell 
inﬁ  ltration (Figure 2, panel C), and neurophagia, which led 
to the conclusion that the cause of death was from the viral 
infection and not from the injection or manipulation of the 
animals.
Dose Dependence
To determine whether the Florida population’s appar-
ent resistance to VEE after peripheral infection was dose-
dependent, 8 additional animals were inoculated with 5 or 6 
log10 PFU (4 animals per dose). In each population, 3 (75%) 
of the rats survived infection (data not shown). One rat in-
oculated with 6 log10 PFU of virus succumbed to disease on 
day 3, whereas another animal inoculated with 5 log10 PFU 
of virus died on day 11, which suggests that the dose could 
have affected disease progression. None of the other inocu-
lated animals showed any clinical signs of illness.
Figure 1. Survival of cotton rats from Florida, Texas, and Harlan after 
subcutaneous inoculation with 3 log10 PFU of enzootic Venezuelan 
equine encephalitis virus (subtypes IE and ID). 
Figure 2. Histologic staining (hematoxylin and eosin) of Florida 
cotton rat tissues 9 days after intracranial inoculation with 3 log10 
PFU of enzootic Venezuelan equine encephalitis virus (subtype 
IE). A) Inﬂ  ammation of the meninges (arrows). B) Inﬂ  ammation of 
the meninges and dilated blood vessels (arrows). C) Perivascular 
cufﬁ  ng of blood vessels (arrow). D) Brain from a noninfected rat. 
(Magniﬁ  cation ×40.)VEEV Infection of Cotton Rats
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Viremia Titers
Viremia proﬁ  les for the Florida rats were similar af-
ter inoculation (3 log10 PFU) with either subtype ID or IE 
VEEV (p>0.05). Peak viremia titers of 6.2 and 5.4 log10 
PFU/mL, respectively, occurred at 24–48 h postinocula-
tion, then became undetectable by days 4–5 postinocula-
tion (Figure 3). The Texas population inoculated with 3–4 
log10 PFU of subtype IE virus and 3 log10 PFU of subtype 
ID VEEV had similar viremia proﬁ  les, with peak titers of 
6.1 and 6.6 log10 PFU/mL, respectively, at 24–48 h.
We found in the Florida population a correlation be-
tween age and peak viremia titers. Younger animals in-
oculated with the IE virus had higher peak titers on days 
1 and 2 postinoculation than did older animals (Figure 4, 
Table 1). In addition, we observed a signiﬁ  cant difference 
in mean viremia titers on day 2 between 3- and 8-week-old 
animals and on day 3 between 5- and 8-week-old animals 
and between 3- and 8-week-old animals (p<0.05).
Differences in Virus Titers among Cotton Rat Populations
No differences in viremia proﬁ  le were observed be-
tween the Texas and Harlan rats, for which VEEV infec-
tion with subtype ID was generally fatal (p>0.05). Viremia 
in the Texas and Harlan rats peaked between 24 and 48 
h postinoculation, with mean titers of ≈6.7 log10 PFU/mL, 
and was undetectable by day 8 postinoculation. In contrast, 
signiﬁ  cant differences were observed in peak viremia titers 
between the Florida and Texas rats inoculated with either 
the ID or IE VEEV subtype (p<0.05). In all cases, Texas 
rats produced higher titers (24 h postinoculation) and had 
a longer duration of viremia than the Florida rats, in which 
no disease was apparent (Figure 3, Tables 2, 3). Similar 
results occurred when Florida and Harlan rats inoculated 
with subtype ID were compared.
Antibody Responses
To determine whether the difference in disease out-
come in Florida versus Texas rats was due to a difference 
in antibody responses, serum was tested by PRNT. In the 
Texas population inoculated with subtype IE VEEV, low 
titers of neutralizing antibodies (NAb) were produced by 
days 5–6 postinoculation (mean titer 20), and mean titers 
never exceeded 40 by day 10 (Figure 5, panel A); however, 
detectable NAb were not produced in all animals that died. 
In contrast, some Florida rats inoculated with the same vi-
rus strain had detectable NAb titers by day 4, and all had 
detectable titers by day 6. NAb titers were signiﬁ  cantly 
lower in the Texas rats on days 5, 6, and 7 (p = 0.02, 0.04, 
0.04, respectively).
When Texas rats were inoculated with the subtype ID 
VEEV strain, even lower NAb titers were produced, despite 
the development of higher viremia titers during the later 
stages, compared with those inoculated with subtype IE. 
Peak NAb titers occurred on day 8 postinoculation (mean 
25), and 2 of the surviving animals had no detectable NAb 
titers (<19) late during infection (day 32). In contrast, in 
all Florida rats, detectable NAb developed by day 4 and 
peaked on day 6 (mean 57), when they were signiﬁ  cantly 
higher (p = 0.004).
To determine the duration of the antibody response in 
the Florida population, we measured NAb titers in 2 rats for 
7 months postinoculation. Titers peaked at 4 months and 
then gradually decreased to the detection limit by 7 months, 
when the experiment was terminated (Figure 5, panel B).
Because NAb were not detected in all infected animals, 
serum samples were further tested by HI and IgM ELISA. 
All rats had detectable HI antibodies by days 5–6 postinoc-
ulation. Although the titers were relatively low (<200) on 
Figure 3. Mean viremia titers of cotton rats from Florida, Texas, and 
Harlan after subcutaneous inoculation with 3 log10 PFU of enzootic 
Venezuelan equine encephalitis virus (subtypes IE and ID). Bars 
indicate standard errors of the means.
Figure 4. Age-dependent viremia in Florida cotton rats inoculated 
subcutaneously with 3 log10 PFU of subtype IE Venezuelan equine 
encephalitis virus. Randomly picked female and male animals 
aged 3–8 weeks were inoculated subcutaneously with 3 log10 PFU. 
Signiﬁ  cant differences were detected on day 2 postinoculation (*p 
= 0.007) and day 3 (**p = 0.02) but not on day 1 (***p = 0.06). Bars 
indicate standard errors of the means.RESEARCH
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day 6, titers increased constantly over the 10 days tested; 
no differences in titers were noted between VEEV subtype 
ID or IE infections in the Texas population. As was found 
by PRNT, HI antibody titers were higher for the Florida 
population than the Texas population, and titers were high-
er in animals inoculated with the ID than with the IE VEEV 
strain (Figure 5, panel C).
Because of volume limitations of daily blood collec-
tion, IgM titrations were performed only on blood samples 
from euthanized rats (2 rats per day per group). Both Flori-
da and Texas populations had similar IgM titers during the 
ﬁ  rst 7 days postinoculation, regardless of the virus used. 
Mean titers ranged from OD 0.3 on day 4 to OD 0.8 by day 
7 in the Texas population and 0.5 in the Florida population 
(Figure 5, panel D).
In summary, NAb titers were higher in Florida rats inoc-
ulated with subtypes ID and IE than in Texas rats inoculated 
with the same viruses. This ﬁ  nding suggests that these ani-
mals may have mounted a more rapid and effective immune 
response that protected against severe VEE infection.
Discussion
Reservoir Status and Potential
S. hispidus, a main reservoir host of VEE complex al-
phaviruses, comprises >22 subspecies in North America 
alone (26) that differ by up to 5% in their cytochrome b 
mitochondrial DNA sequences (27). Because some but not 
all North American populations occur in regions enzootic 
for VEE complex alphaviruses (e.g., EVEV in Florida), 
we attempted to better understand the host-VEEV interac-
tions by inoculating 3 different populations with enzootic 
VEEV strains. Cotton rats from the enzootic area of south-
ern Florida (sympatric with EVEV) responded to VEEV 
infection as expected: moderate viremia titers, seroconver-
sion by days 4–5 postinoculation coincident with viremia 
cessation, and few deaths and little detectable disease. This 
apparently commensal relationship could reﬂ  ect long-term 
selection for cotton rat resistance to  EVEV in Florida. Al-
though EVEV is a relatively benign virus in laboratory ro-
dents, the ancestral form of EVEV, believed to be a subtype 
ID VEEV strain from Panama or South America, is more 
virulent (32).
In contrast, rats from 2 nonenzootic locations (the Har-
lan and Texas populations) had dramatically different out-
comes: severe disease often culminated in clinical signs of 
encephalitis and high mortality rates. This difference in dis-
ease and survival was more pronounced than that reported 
in other studies of VEEV-reservoir host interactions, some 
of which suggested that cotton rats die because of experi-
mental manipulations or anesthesia rather than from a viral 
cause (19–21,24). Our results indicate that VEEV was the 
cause of death for most or all of our rats, and signs of en-
cephalitis were consistent with those described in VEEV-
infected mice or guinea pigs (8,33,34). The rats infected in 
previous studies had several different geographic origins 
(Arizona, North Carolina, Florida, and Panama). Of these, 
only Panama and Florida are enzootic for VEE complex 
alphaviruses. North Carolina is enzootic for another closely 
related alphavirus, EEEV, for which birds are thought to 
be the main reservoirs (35). These allopatric rat popula-
tions should be reexamined to further test the hypothesis 
that lack of exposure to VEE complex or other alphaviruses 
has resulted in no selection for resistance. On the basis of 
previous susceptibility studies, the peak viremia titers in all 
infected cotton rats were sufﬁ  cient to infect known enzo-
otic vector mosquitoes (36,37).
Reservoir hosts play an important role in the mainte-
nance and spread of zoonotic viruses. They generally show 
little or no disease after infection with VEEV and most 
Table 1. Mean viremia titers of Florida cotton rats inoculated 
subcutaneously with Venezuelan equine encephalitis virus, 
subtype IE* 
Age, wk 
Day postinfection  3 (n = 2)  5 (n = 2)  8 (n = 4) 
1 6.7 6.2 5.6
2 6.2 5.4 4.5
3 4.6 5.3 2.4
4 1.9 1.9 1.9
5 1.9 1.9 1.9
6 1.9 1.9 1.9
*Titers are expressed as log10 PFU/mL.; 1.9 log10 PFU/mL is the limit of 
detection of the plaque assay. 
Table 2. Mean viremia titers of Florida, Texas, and Harlan cotton rats inoculated subcutaneously with Venezuelan equine encephalitis 
virus, subtype ID or IE* 
Cotton rat population and virus subtype 
Day postinfection  Florida, IE Florida, ID Texas, IE Texas, ID Harlan, ID
1 6.1 ± 0.2 5.2 ± 0.2 6.3 ± 0.2 6.1 ± 0.2 6.8 ± 0.9
2 5.2 ± 0.2 5.4 ± 0.1 6.4 ± 0.1 6.6 ± 0.2 5.8 ± 0.9
3 3.7 ± 0.4 4.1 ± 0.2 5.6 ± 0.2 6.3 ± 0.2 6.5 ± 0.5
4 <1.9 2.3 ± 0.2  3.8 ± 0.3  5.6 ± 0.2  4.7 ± 0.8 
5 <1.9 <1.9 2.6 ± 0.3  5.0 ± 0.5  3.9 ± 0.1 
6 <1.9 <1.9 2.2 ± 0.2  3.6 ± 0.7  3.9 ± 0.2 
7 <1.9 <1.9 <1.9 <1.9 2.0 ± 0.0 
8 <1.9 <1.9 <1.9 <1.9 2.1 ± 0.3 
*Titers are expressed as log10 PFU/mL ± standard error; 1.9 log10 PFU/mL is the limit of detection of the plaque assay. VEEV Infection of Cotton Rats
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other zoonotic viruses, which presumably reﬂ  ects long-term 
selection for resistance (1,2). This resistance is little studied 
and poorly understood, yet it might provide insight into im-
proved treatments for arbovirus infections in humans. Our 
ﬁ  ndings may also have implications for VEEV ecology, es-
pecially in the event of virus introduction into a nonenzootic 
region, as occurred during the 1971 Texas VEEV epizootic 
(38,39). During such a scenario, virus-induced deaths might 
deplete cotton rat populations, depending on the VEEV 
transmission levels and the length of the outbreak.
Viremia and Immunologic Responses
The differences in viremia proﬁ  les exhibited by the 
VEE-sympatric versus VEE-allopatric cotton rat popu-
lations could explain the different disease outcomes. Al-
though peaks of viremia titers were similar for both subspe-
cies, durations of viremia differed. The prolonged viremia 
observed in the Texas and Harlan animals may reﬂ  ect a 
poor or delayed innate or adaptive immune response, which 
led to sustained viral replication and death. This could be 
an indirect effect of replication in lymphatic tissues leading 
to immunosuppression. Although peak viremia titers ap-
peared to be age-dependent in the Florida population inoc-
ulated with the subtype IE VEEV strain, disease outcomes 
between age groups, which might reﬂ  ect maturation of the 
immune system, did not differ signiﬁ  cantly. Antibody titers 
in both populations of cotton rats after inoculation with ei-
ther virus strain were relatively low.
Table 3. Statistical comparisons (p values) among viremia titers in Texas and Florida cotton rats inoculated with Venezuelan equine
encephalitis virus, subtype IE or ID* 
Day postinfection 
Texas vs. Florida,  
subtype IE 
Texas vs. Florida, subtype 
ID
Subtype IE vs. ID,  
Texas  Subtype IE vs. ID, Florida 
1 0.123 0.018 0.590 0.078
2 5.0 × 10
–4 4.69 × 10
–5 0.506 0.078
3 9.75 × 10
–7 2.72 × 10
–6 0.506 0.215
4 2.82 × 10
–10 3.66 × 10
–8 0.348 0.751
5 1.31 × 10
–5 5.71 × 10
–5 0.058 1
6 0.051 0.010 0.123 –
*Numbers in boldface indicate statistically significant differences (analysis of variance). 
Figure 5. Antibody responses in cotton rats from Florida and Texas. A) Neutralizing antibody (NAb) titers in Florida group (n = 3–11) and 
Texas group (n = 1–17) inoculated with subtypes IE or ID Venezuelan equine encephalitis virus (VEEV). B) Long-term NAb titers in Florida 
rats infected with subtype IE VEEV (n = 2). C) Hemagglutination inhibition (HI) antibody titers for Florida (n = 2–10) and Texas (n = 1–16) 
rats inoculated with subtype IE VEEV. D) Immunoglobulin M antibody titers for Florida and Texas rats infected with subtype IE VEEV 
(n = 2).  OD, optical density.RESEARCH
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These ﬁ  ndings contrast with results of a previously 
published study of EVEV infection of cotton rats from the 
same 2 geographic regions (25). In that study, both sub-
species of rats survived infection, exhibited similar peak 
viremia titers, and had high antibody titers within 9 days 
postinoculation; it was suggested that the innate immune 
response was involved. EVEV, enzootic in South Florida, 
is less virulent in laboratory rodents than in most other vi-
ruses in the VEE complex, including the subtypes we used 
(19,40). Presumably due to this lack of virulence, Florida 
and Texas strains of cotton rats tested produced protective 
antibodies and survived EVEV infection (25).
Our data from the same 2 rat populations but inocu-
lated with more virulent stains of VEEV present a different 
picture. Although the innate immune response may be in-
volved as well, antibody detection correlated with the dis-
appearance of viremia. The capability of Florida cotton rats 
to produce antibodies against VEEV early may allow them 
to better control replication and survive. Antibodies against 
VEEV persist for at least 6 months in laboratory-infected 
cotton rats (25). The average lifespan of cotton rats in na-
ture is estimated to be ≈6–8 months (41).
To identify protective mechanisms in the Florida 
population, additional studies focusing more on the innate 
immune responses of enzootic and nonenzootic cotton rat 
populations are needed. This could be approached by cross-
breeding the Texas and the Florida rats and studying the 
offspring. Elucidation of protective mechanisms may be 
useful for developing new strategies for treating human or 
equine infections.
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